CAS 92623-85-3: Milnacipran
Formula:C15H22N2O
InChI:InChI=1/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/s2
InChI key:InChIKey=GJJFMKBJSRMPLA-UYWMCZCJNA-N
SMILES:C(N(CC)CC)(=O)[C@]1([C@@H](CN)C1)C2=CC=CC=C2
Synonyms:- Milnacipran
- rel-(1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
- Midalcipran
- Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(±)-
- Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1R,2S)-rel-
Sort by
Found 6 products.
Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-,(1R,2S)-rel-
CAS:Formula:C15H22N2OColor and Shape:SolidMolecular weight:246.3480(1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
CAS:Controlled ProductRiluzole is a drug that inhibits the synthesis of glutamate and aspartate, which are neurotransmitters in the central nervous system. It also inhibits the 5-HT2 receptors, which are associated with autoimmune diseases. Riluzole can be used to treat diseases such as bowel disease and Crohn's disease. This drug has been shown to have a low potential for drug interactions because it does not inhibit any cytochrome P450 enzymes or other enzymes involved in drug metabolism. Riluzole does not inhibit reuptake of serotonin or dopamine and does not bind to any receptor activity.Formula:C15H22N2OPurity:Min. 95%Molecular weight:246.35 g/molMilnacipran
CAS:Milnacipran, an SNRI with 85% bioavailability, treats fibromyalgia and is well absorbed orally.Formula:C15H22N2OColor and Shape:SolidMolecular weight:246.35Milnacipran Hydrochloride
CAS:Formula:C15H22N2O·HClPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:282.81
